pms-Citalopram Indications/Uses

Adults: pms-CITALOPRAM (citalopram hydrobromide) is indicated for: the symptomatic relief of depressive illness.
The relapse rate was significantly lower in citalopram hydrobromide-treated patients than in placebo-treated patients in two placebo-controlled studies that were conducted over a 24-week period in patients who responded to 6 or 8 weeks of acute treatment with citalopram hydrobromide (see Pharmacology: Pharmacodynamics: Clinical Trials under Actions). Nevertheless, the physician who elects to use citalopram hydrobromide for extended periods should periodically re-evaluate the long-term usefulness of the drug for the individual patient.
Geriatrics (≥ 65 years of age): Elderly patients should be administered lower doses and a lower maximum dose (see Recommended Dose and Dosage Adjustment: Geriatrics (≥ 65 years of age) under Dosage & Administration and Use in Elderly under Precautions).
Pediatrics (< 18 years of age): pms-CITALOPRAM is not indicated for use in patients below the age of 18 (see General: Potential Association with Behavioral and Emotional Changes, Including Self-Harm under Precautions).